Aniline analogs as glycogen synthase activators
US7939569B1 · kind B1 · utility
1Cited by
0References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 20, 2010 |
| Grant date | May 10, 2011 |
| Priority date | — |
| Expiry date | Oct 20, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are compounds of the formula (I):as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of metabolic diseases and disorders such as, for example, type II diabetes mellitus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.